-+ 0.00%
-+ 0.00%
-+ 0.00%

Merck, Pfizer, Astellas Drug Combo Succeeds in 2nd Phase 3 Bladder Cancer Study

Dow Jones·12/17/2025 12:38:00

Please log in to view news